Migraine-anxiety related dizziness (MARD): A new disorder?

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 1, 2005, Pages 1-8

  Furman, J M ^a,b   Balaban, C D ^a   Jacob, R G ^a   Marcus, D A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b University of Pittsburgh School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CLONAZEPAM; DIAZEPAM; IMIPRAMINE; MECLOZINE; PAROXETINE; PROCHLORPERAZINE; PROMETHAZINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; TRIPTAN DERIVATIVE; UNCLASSIFIED DRUG; VERAPAMIL;

ANXIETY DISORDER; BALANCE DISORDER; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; DISEASE ASSOCIATION; DIZZINESS; EDITORIAL; HUMAN; MIGRAINE; MIGRAINE ANXIETY RELATED DIZZINESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STRESS; TREATMENT OUTCOME; VERTIGO; VESTIBULAR SYSTEM; VESTIBULE;

ANXIETY; DIZZINESS; HUMANS; MIGRAINE DISORDERS;

EID: 10944223522     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.048926     Document Type: Editorial

References (102)

1. Neuhauser H, Leopold M, von Brevern M, et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001;56:436-41.
2. Furman JM, Jacob RG. Psychiatric dizziness. Neurology 1997;48:1161-6.
3. Yardley L. Overview of psychologic effects of chronic dizziness and balance disorders. Otolaryngol Clin North Am 2000;33:603-16.
4. Furman JM, Marcus DA, Balaban CD. Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol 2003;16:5-13.
5. Marazziti D, Toni C, Pedri S, et al. Prevalence of headache syndromes in panic disorder. Int Clin Psychopharmacol 1999;14:247-51.
6. Jacob RG, Brandt T, Furman J. Psychiatric aspects of dizziness and imbalance. In: Bronstein A, Brandt T, Wollacott M, Nutt J, eds. Clinical disorders of balance, posture and gait, 2nd ed. London: Arnold, 2003:245-85.
7. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181-5.
8. Diagnostic and statistical manual of mental disorders (DSM-IV), 4th ed. Washington DC: American Psychiatric Association, 1994.
9. Kayan A, Hood JD. Neuro-otological manifestations of migraine. Brain 1984;107:1123-42.
10. The International Classification of Headache Disorders (2nd edition). Cephalagia 2004;24(suppl 1):1-96.
11. Burstein R, Yarnitsky D, Goor-Aryeh I, et al. An association between migraine and cutaneous allodynia. Ann Neurol 2000;47:614-24.
12. Bayazit Y, Yilmaz M, Mumbuc S, et al. Assessment of migraine-related cochleovestibular symptoms. Rev Laryngol Otol Rhinol (Bord) 2001;122:85-8.
13. Ishizaki K, Mori N, Takeshima T, et al. Static stabilometry in patients with migraine and tension-type headache during a headache-free period. Psychiatry Clin Neurosci 2002;56:85-90.
14. Lee H, Sohn SI, Jung DK, et al. Migraine and isolated recurrent vertigo of unknown cause. Neural Res 2002;24:663-5.
15. Kuritzky A, Toglia UJ, Thomas D. Vestibular function in migraine. Headache 1981;21:110-12.
16. Cutrer FM, Baloh RW. Migraine-associated dizziness. Headache 1992;32:300-4.
17. Cass SP, Furman JM, Ankerstjerne K, et al. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol 1997;106:182-9.
18. Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope 1998;108:1-28.
19. Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 1999;246:883-92.
20. Thakar A, Anjaneyulu C, Deka RC. Vertigo syndromes and mechanisms in migraine. J Laryngol Otol 2001;115:782-7.
21. Marcus DA, Kapelewski C, Rudy TE, et al. Diagnosis of migrainous vertigo: validity of a structured interview. Med Sci Monitor 2004;10:CR197-201.
22. May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 1999;19:115-27.
23. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med 2002;346:257-70.
24. Schuerger RJ, Balaban CD. Organization of the coeruleo-vestibular pathway in rats, rabbits, and monkeys. Brain Res Brain Res Rev 1999;30:189-217.
25. Halberstadt AL, Balaban CD. Organization of projections from the raphe nuclei to the vestibular nuclei in rats. Neuroscience 2003;120:573-94.
26. Cassidy EM, Tomkins E, Dinan T, et al. Central 5-HT receptor hypersensitivity in migraine without aura. Cephalgia 2003;23:29-34.
27. Vass Z, Shore SE, Nuttall AL, et al. Direct evidence of trigeminal innervation of the cochlear blood vessels. Neuroscience 1998;84:559-67.
28. Vass Z, Steyger PS, Hordichok AJ, et al. Capsaicin stimulation of the cochlea and electric stimulation of the trigeminal ganglion mediate vascular permeability in cochlear and vertebrobasilar arteries: a potential cause of inner ear dysfunction in headache. Neuroscience 2001;103:189-201.
29. Scarfone E, Ulfendahl M, Lundeberg T. The cellular localization of the neuropeptides substance P, neurokinin A, calcitonin gene-related peptide and neuropeptide Y in guinea-pig vestibular sensory organs: a high-resolution confocal microscopy study. Neuroscience 1996;75:587-600.
30. Marco RA, Hoffman LF, Wackym PA, et al. Distribution of calcitonin gene-related peptide immunoreactivity in vestibular efferent neurons of the chinchilla. Hear Res 1996;97:95-101.
31. Kong WJ, Scholtz AW, Kammen-Jolly K, et al. Ultrastructural evaluation of calcitonin gene-related peptide immunoreactivity in the human cochlea and vestibular endorgans. Eur J Neurosci 2002;15:487-97.
32. Staab JP. Diagnosis and treatment of psychologic symptoms and psychiatric disorders in patients with dizziness and imbalance. Otolaryngol Clin North Am 2000;33:617-36.
33. Persoons P, Luyckx K, Desloovere C, Vandenberghe J, Fischler B. Anxiety and mood disorders in otorhinolaryngology outpatients presenting with dizziness: validation of the self-administered PRIME-MD Patient Health Questionnaire and epidemiology. Gen Hosp Psychiatry 2003;25:316-23.
34. Perna G, Dario A, Caldirola D, et al. Panic disorder: the role of the balance system. J Psychiatr Res 2001;35:279-86.
35. Yardley L, Britton J, Lear S, et al. Relationship between balance system function and agoraphobic avoidance. Behav Res Ther 1995;33:435-9.
36. Jacob RG, Furman JM, Durrant JD, et al. Panic, agoraphobia, and vestibular dysfunction. Am J Psychiatry 1996;153:503-12.
37. Jacob RG, Furman JM, Durrant JD, et al. Surface dependence: a balance control strategy in panic disorder with agoraphobia. Psychosom Med 1997;59:323-30.
38. Nilsson A, Henriksson NG, Magnusson PA, et al. Vertigo and dizzines reflecting functional disorders. Adv Otorhinolaryngol 1979;25:93-9.
39. Eckhardt-Henn A, Breuer P, Thomalske C, et al. Anxiety disorders and other psychiatric subgroups in patients complaining of dizziness. J Anxiety Disord 2003;17:369-88.
40. Staab JP, Ruckenstein MJ. Which comes first? Psychogenic dizziness versus otogenic anxiety. Laryngoscope 2003;113:1714-18.
41. Pollak L, Klein C, Rafael S, et al. Anxiety in the first attack of vertigo. Otolaryngol Head Neck Surg 2003;128:829-34.
42. Soderman AC, Bagger-Sjoback D, Bergenius J, et al. Factors influencing qualify of life in patients with Meniere's disease, identified by a multidimensional approach. Otol Neurotol 2002;23:941-8.
43. Jacob RG. Panic disorder and the vestibular system. Psychiatr Clin North Am 1988;11:361-74.
44. Minor LB, Halswanter T, Straumann D, et al. Hyperventilation-induced nystagmus in patients with vestibular schwannoma. Neurology 1999;53:2158-68.
45. Sakellari V, Bronstein AM, Corna S, et al. The effects of hyperventilation on postural control mechanisms. Brain 1997;120:1659-73.
46. Balaban CD, Beryozkin G. Vestibular nucleus projections to nucleus tractus solitarius and the dorsal motor nucleus of the vagus nerve: potential substrates for vestibulo-autonomic interactions. Exp Brain Res 1994;98:200-12.
47. Yates BJ, Grelot L, Kerman IA, et al. Organization of vestibular inputs to nucleus tractus solitarius and adjacent structures in cat brain stem. Am J Physiol 1994;267:R974-83.
48. Balaban CD. Vestibular nucleus projections to the parabrachial nucleus in rabbits: implications for vestibular influences on the autonomic nervous system. Exp Brain Res 1996;108:367-81.
49. Porter JD, Balaban CD. Connections between the vestibular nuclei and brain stem regions that mediate autonomic function in the rat. J Vestib Res 1997;7:63-76.
50. Balaban CD. Vestibular nucleus projections to the Edinger-Westphal and anteromedian nuclei of rabbits. Brain Res 2003;963:121-31.
51. Balaban CD, McGee DM, Zhou J, et al. Responses of primate caudal parabrachial nucleus and Kolliker-fuse nucleus neurons to whole body rotation. J Neurophysiol 2002;88:3175-93.
52. Balaban CD. Projections from the parabrachial nucleus to the vestibular nuclei: potential substrates for autonomic and limbic influences on vestibular responses. Brain Res 2004;996:126-37.
53. LeDoux JE, Iwata J, Cicchetti P, et al. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci 1988;8:2517-29.
54. Gorman JM, Kent JM, Sullivan GM, et al. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry 2000;157:493-505.
55. Charney DS, Deutch A. A functional neuroanatomy of anxiety and fear: implications for the pathophysiology and treatment of anxiety disorders. Crit Rev Neurobiol 1996;10:419-46.
56. Guldin WO, Grusser OJ. Is there a vestibular cortex? Trends Neurosci 1998;21:254-9.
57. Lobel E, Kleine JF, Bihan DL, et al. Functional MRI of galvanic vestibular stimulation. J Neurophysiol 1998;80:2699-709.
58. Akbarian S, Grusser OJ, Guldin WO. Thalamic connections of the vestibular cortical fields in the squirrel monkey (Saimiri sciureus). J Comp Neurol 1992;326:423-41.
59. Lang W, Buttner-Ennever JA, Buttner U. Vestibular projections to the monkey thalamus: an autoradiographic study. Brain Res 1979;177:3-17.
60. Kotchabhakdi N, Rinvik E, Walberg F, et al. The vestibulothalamic projections in the cat studied by retrograde axonal transport of horseradish peroxidase. Exp Brain Res 1980;40:405-18.
61. Maciewicz R, Phipps BS, Bry J, et al. The vestibulothalamic pathway: contribution of the ascending tract of Deiters. Brain Res 1982;252:1-11.
62. Nagata S. The vestibulothalamic connections in the rat: a morphological analysis using wheat germ agglutinin-horseradish peroxidase. Brain Res 1986;376:57-70.
63. Shiroyama T, Kayahara T, Yasui Y, et al. The vestibular nuclei of the rat project to the lateral part of the thalamic parafascicular nucleus (centromedian nucleus in primates). Brain Res 1995;704:130-4.
64. Bucher SF, Dieterich M, Wiesmann M, et al. Cerebral functional magnetic resonance imaging of vestibular, auditory, and nociceptive areas during galvanic stimulation. Ann Neurol 1998;44:120-5.
65. Schuerger RJ, Balaban CD. Immunohistochemical demonstration of regionally selective projections from locus coeruleus to the vestibular nuclei in rats. Exp Brain Res 1993;92:351-9.
66. Loughlin SE, Foote SL, Grzanna R. Efferent projections of nucleus locus coeruleus: morphologic subpopulations have different etferent targets. Neuroscience 1986;18:307-19.
67. Balaban CD. Neural substrates linking balance control and anxiety. Physiol Behav 2002;77:469-75.
68. Collins WE, Poe RH. Amphetamine, arousal, and human vestibular nystagmus. J Pharmacol Exp Ther 1962;138:120-5.
69. Collins WE. Some etfects of sleep loss on vestibular responses. Aviat Space Environ Med 1988;59:523-9.
70. Collins WE, Guedry FE Jr. Arousal etfects and nystagmus during prolonged constant angular acceleration. Acta Otolaryngol 1962;54:349-62.
71. Kasper J, Diefenhardt A, Mackert A, et al. The vestibulo-ocular response during transient arousal shifts in man. Acta Otolaryngol 1992;112:1-6.
72. Staab JP, Ruckenstein MJ, Solomon D, et al. Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. Arch Otolaryngol Head Neck Surg 2002;128:554-60.
73. Pratt J, Jenner P, Reynolds EH, et al. Clonazepam induces decreased serotoninergic activity in the mouse brain. Neuropharmacology 1979;18:791-9.
74. Collinge J, Pycock CJ, Taberner PV. Studies on the interaction between cerebral 5-hydroxytryptamine and gamma-aminobutyric acid in the mode of action of diazepam in the rat. Br J Pharmacol 1983;79:637-43.
75. Haleem DJ, Batool F. Regionally specific effects of diazepam on brain serotonin metabolism in rats: sustained effects following repeted administration. Life Sci 1996;59:239-46.
76. Coupland NJ, Bell CJ, Potokar JP. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol 1996;16:356-62.
77. Black DW, Wesner R, Gabel J. The abrupt discontinuation of fluvoxamine in patients with ponic disorder. J Clin Psychiatry 1993;54:146-9.
78. Petrov T, Krukoff TL, Jhamandas JH. The hypothalamic paraventricular and lateral parabrachial nuclei receive collaterals from raphe nucleus neurons: a combined double retrograde and immunocytochemical study. J Comp Neurol 1992;318:18-26.
79. Petrov T, Krukoff TL, Jhamandas JH. Chemically defined collateral projections from the pons to the central nucleus of the amygdala and hypothalamic paraventricular nucleus in the rat. Cell Tissue Res 1994;277:289-95.
80. Kazakov VN, Kravtsov P, Krakhotkina ED, et al. Sources of cortical, hypothalamic and spinal serotonergic projections: topical organization within the nucleus raphe dorsalis. Neuroscience 1993;56:157-64.
81. Kirifides ML, Simpson KL, Lin RC, et al. Topographic organization and neurochemical identity of dorsal raphe neurons that project to the trigeminal somatosensory pathway in the rat. J Comp Neurol 2001;435:325-40.
82. Vertes RP. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 1991;313:643-68.
83. Halberstadt AL, Balaban CD, Schor RH. Individual serotonerigic dorsal raphe cells send collateralized projects to amygdala and vestibular nuclei. Soc Neurosci Abstr 2001;27:806-8.
84. Breslau N, Schultz LR, Stewart WF, et al. Headache types and panic disorder: directionality and specificity. Neurology 2001;56:350-4.
85. Guidetti V, Galli F, Fabrizi P, et al. Headache and psychiatric comorbidity: clinical aspects and outcome in an 8-year follow-up study. Cephalalgia 1998;18:455-62.
86. Floyd NS, Price JL, Ferry AT, et al. Orbitomedial prefrontal cortical projections to distinct longitudinal columns of the periaqueductal gray in the rat. J Comp Neurol 2000;422:556-78.
87. Rizvi TA, Ennis M, Behbehani MM, et al. Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: topography and reciprocity. J Comp Neurol 1991;303:121-31.
88. Parades J, Winters RW, Schneiderman N, et al. Afferents to the central nucleus of the amygdala and functional subdivisions of the periaqueductal gray: neuroanatomical substrates for affective behavior. Brain Res 2000;887:157-73.
89. Bandler R, Price JL, Keay KA. Brain mediation of active and passive emotional coping. Prog Brain Res 2000:331-349.
90. Staab JP, Ruckenstein MJ, Amsterdam JD. A prospective trial of Sertraline for chronic subjective dizziness. Laryngoscope 2004;14:1637-41.
91. Perna G, Alpini D, Caldirola D, et al. Serotonergic modulation of the balance system in panic disorder: an open study. Depress Anxiety 2003;17:101-6.
92. Furman JM, Jacob RG. A clinical taxonomy of dizziness and anxiety in the otoneurological setting. J Anxiety Disord 2001;15:9-26.
93. Jacob RG, Whitney SL, Detweiler-Shostak G, et al. Vestibular rehabilitation for patients with agoraphobia and vestibular dysfunction: a pilot study. J Anxiety Disord 2001;15: 131-46.
94. Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol 1997;18:350-4.
95. Reploeg MD, Goebel JA. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol 2002;23:364-71.
96. Perello E, Esteller E, Colls A, et al. (Efficacy and safety of dotarizine vs. cinnarizine in the symptomatic treatment of acute balance disorders (common vertigo)). An Otorrinolaringol Ibero Am 1998;25:291-310.
97. Muzina DJ, El-Sayegh S, Calabrese JR. Antiepileptic drugs in psychiatry-focus on randomized controlled trial. Epilepsy Res 2002;50:195-202.
98. Allgulander C, Nilsson B. (A nationwide study in primary health care: One out of four patients suffers from anxiety and depression). Lakartidningen 2003;100:832-8.
99. Foster RH, Gao KL. A review of its pharmacology and therapeutic potential in the management of panic disorder. CNS Drugs 1997;8:163-88.
100. Herdman S. Vestibular rehabilitation, 2nd ed. Philadelphia: Davis, 2000.
101. Whitney SL, Wrisley DM, Brown KE, et al. Physical therapy for migraine-related vestibulopathy and vestibular dysfunction with history of migraine. Laryngoscope 2000;110:1528-34.
102. Balaban CD, Thayer JF. Neurological bases for balance-anxiety links. J Anxiety Disord 2001;15:53-79.